会員登録
ログイン
【4576】デ・ウエスタン・セラピテクス研究所
創薬。眼病に注力。
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.12 | 2024/02/09 | 当初予 | 400 | - | - | - | -1,500 | - | - | - | -1,510 | - | - | - | -1,510 | - | - | - |
| 2023.12 | 2024/02/09 | 実 | 428 | ↑ | +4.4% | +7.0% | -798 | ↑ | +6.1% | +43.0% | -796 | ↑ | +6.4% | +43.5% | -812 | ↑ | +6.7% | +41.6% |
| 2023.12 | 2023/12/14 | 修正予 | 410 | ↑ | +2.5% | +2.5% | -850 | ↑ | +39.3% | +39.3% | -850 | ↑ | +39.7% | +39.7% | -870 | ↑ | +37.4% | +37.4% |
| 2023.12 | 2023/11/10 | Q3予 | 400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,410 | → | 0.0% | 0.0% | -1,390 | → | 0.0% | 0.0% |
| 2023.12 | 2023/08/10 | Q2予 | 400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,410 | → | 0.0% | 0.0% | -1,390 | → | 0.0% | 0.0% |
| 2023.12 | 2023/05/12 | Q1予 | 400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,410 | → | 0.0% | 0.0% | -1,390 | → | 0.0% | 0.0% |
| 2023.12 | 2023/02/13 | 当初予 | 400 | - | - | - | -1,400 | - | - | - | -1,410 | - | - | - | -1,390 | - | - | - |
| 2022.12 | 2023/02/13 | 実 | 448 | ↑ | +1.8% | +21.1% | -305 | ↑ | +23.8% | +55.8% | -295 | ↑ | +24.4% | +57.9% | -429 | ↓ | -12.9% | +36.0% |
| 2022.12 | 2022/11/18 | 修正予 | 440 | ↑ | +18.9% | +18.9% | -400 | ↑ | +42.0% | +42.0% | -390 | ↑ | +44.3% | +44.3% | -380 | ↑ | +43.3% | +43.3% |
| 2022.12 | 2022/11/10 | Q3予 | 370 | → | 0.0% | 0.0% | -690 | → | 0.0% | 0.0% | -700 | → | 0.0% | 0.0% | -670 | → | 0.0% | 0.0% |
| 2022.12 | 2022/08/09 | Q2予 | 370 | → | 0.0% | 0.0% | -690 | → | 0.0% | 0.0% | -700 | → | 0.0% | 0.0% | -670 | → | 0.0% | 0.0% |
| 2022.12 | 2022/05/12 | Q1予 | 370 | → | 0.0% | 0.0% | -690 | → | 0.0% | 0.0% | -700 | → | 0.0% | 0.0% | -670 | → | 0.0% | 0.0% |
| 2022.12 | 2022/02/10 | 当初予 | 370 | - | - | - | -690 | - | - | - | -700 | - | - | - | -670 | - | - | - |
| 2021.12 | 2022/02/10 | 実 | 414 | ↑ | +3.5% | +21.8% | -171 | ↑ | +10.0% | +70.5% | -159 | ↑ | +16.3% | +72.6% | -148 | ↑ | +12.9% | +72.1% |
| 2021.12 | 2021/11/19 | 修正予 | 400 | → | 0.0% | +17.6% | -190 | ↑ | +34.5% | +67.2% | -190 | ↑ | +34.5% | +67.2% | -170 | ↑ | +37.0% | +67.9% |
| 2021.12 | 2021/11/11 | Q3予 | 400 | → | 0.0% | +17.6% | -290 | → | 0.0% | +50.0% | -290 | → | 0.0% | +50.0% | -270 | → | 0.0% | +49.1% |
| 2021.12 | 2021/10/11 | 修正予 | 400 | ↑ | +17.6% | +17.6% | -290 | ↑ | +50.0% | +50.0% | -290 | ↑ | +50.0% | +50.0% | -270 | ↑ | +49.1% | +49.1% |
| 2021.12 | 2021/08/10 | Q2予 | 340 | → | 0.0% | 0.0% | -580 | → | 0.0% | 0.0% | -580 | → | 0.0% | 0.0% | -530 | → | 0.0% | 0.0% |
| 2021.12 | 2021/05/13 | Q1予 | 340 | → | 0.0% | 0.0% | -580 | → | 0.0% | 0.0% | -580 | → | 0.0% | 0.0% | -530 | → | 0.0% | 0.0% |
| 2021.12 | 2021/02/12 | 当初予 | 340 | - | - | - | -580 | - | - | - | -580 | - | - | - | -530 | - | - | - |
| 2020.12 | 2021/02/12 | 実 | 355 | → | 0.0% | +14.5% | -265 | → | 0.0% | +8.6% | -289 | → | 0.0% | +6.8% | -276 | → | 0.0% | -15.0% |
| 2020.12 | 2021/01/14 | 修正予 | 355 | ↑ | +14.5% | +14.5% | -265 | ↑ | +32.1% | +8.6% | -289 | ↑ | +29.5% | +6.8% | -276 | ↑ | +18.8% | -15.0% |
| 2020.12 | 2020/11/12 | Q3予 | 310 | → | 0.0% | 0.0% | -390 | → | 0.0% | -34.5% | -410 | → | 0.0% | -32.3% | -340 | → | 0.0% | -41.7% |
| 2020.12 | 2020/08/13 | Q2予 | 310 | → | 0.0% | 0.0% | -390 | → | 0.0% | -34.5% | -410 | → | 0.0% | -32.3% | -340 | → | 0.0% | -41.7% |
| 2020.12 | 2020/05/14 | Q1予 | 310 | → | 0.0% | 0.0% | -390 | → | 0.0% | -34.5% | -410 | → | 0.0% | -32.3% | -340 | → | 0.0% | -41.7% |
| 2020.12 | 2020/04/16 | 修正予 | 310 | → | 0.0% | 0.0% | -390 | ↓ | -34.5% | -34.5% | -410 | ↓ | -32.3% | -32.3% | -340 | ↓ | -41.7% | -41.7% |
| 2020.12 | 2020/02/13 | 当初予 | 310 | - | - | - | -290 | - | - | - | -310 | - | - | - | -240 | - | - | - |
| 2019.12 | 2020/02/13 | 実 | 580 | → | 0.0% | +16.0% | 117 | ↑ | +6.4% | +290.0% | 109 | ↑ | +9.0% | +445.0% | 133 | ↑ | +2.3% | +121.7% |
| 2019.12 | 2019/12/12 | 修正予 | 580 | ↑ | +16.0% | +16.0% | 110 | ↑ | +266.7% | +266.7% | 100 | ↑ | +400.0% | +400.0% | 130 | ↑ | +116.7% | +116.7% |
| 2019.12 | 2019/11/14 | Q3予 | 500 | → | 0.0% | 0.0% | 30 | → | 0.0% | 0.0% | 20 | → | 0.0% | 0.0% | 60 | → | 0.0% | 0.0% |
| 2019.12 | 2019/08/08 | Q2予 | 500 | → | 0.0% | 0.0% | 30 | → | 0.0% | 0.0% | 20 | → | 0.0% | 0.0% | 60 | → | 0.0% | 0.0% |
| 2019.12 | 2019/05/15 | Q1予 | 500 | → | 0.0% | 0.0% | 30 | → | 0.0% | 0.0% | 20 | → | 0.0% | 0.0% | 60 | → | 0.0% | 0.0% |
| 2019.12 | 2019/02/14 | 当初予 | 500 | - | - | - | 30 | - | - | - | 20 | - | - | - | 60 | - | - | - |
| 2018.12 | 2019/02/14 | 実 | 292 | ↑ | +4.3% | -54.0% | -786 | ↓ | -2.7% | -27.8% | -796 | ↓ | -2.7% | -27.4% | -748 | ↓ | -2.5% | -37.2% |
| 2018.12 | 2018/12/27 | 修正予 | 280 | ↓ | -26.3% | -55.9% | -765 | ↑ | +6.1% | -24.4% | -775 | ↑ | +6.1% | -24.0% | -730 | ↑ | +2.0% | -33.9% |
| 2018.12 | 2018/11/08 | Q3予 | 380 | → | 0.0% | -40.2% | -815 | → | 0.0% | -32.5% | -825 | → | 0.0% | -32.0% | -745 | → | 0.0% | -36.7% |
| 2018.12 | 2018/08/09 | Q2予 | 380 | → | 0.0% | -40.2% | -815 | → | 0.0% | -32.5% | -825 | → | 0.0% | -32.0% | -745 | → | 0.0% | -36.7% |
| 2018.12 | 2018/07/26 | 修正予 | 380 | ↓ | -40.2% | -40.2% | -815 | ↓ | -32.5% | -32.5% | -825 | ↓ | -32.0% | -32.0% | -745 | ↓ | -36.7% | -36.7% |
| 2018.12 | 2018/05/10 | Q1予 | 635 | → | 0.0% | 0.0% | -615 | → | 0.0% | 0.0% | -625 | → | 0.0% | 0.0% | -545 | → | 0.0% | 0.0% |
| 2018.12 | 2018/02/13 | 当初予 | 635 | - | - | - | -615 | - | - | - | -625 | - | - | - | -545 | - | - | - |
| 2017.12 | 2018/02/13 | 実 | 254 | ↑ | +1.6% | -12.4% | -633 | ↓ | -0.5% | +58.5% | -668 | ↑ | +0.3% | +56.3% | -1,563 | ↓ | -0.2% | -8.2% |
| 2017.12 | 2017/12/27 | 修正予 | 250 | ↓ | -34.2% | -13.8% | -630 | ↑ | +7.4% | +58.7% | -670 | ↑ | +6.9% | +56.2% | -1,560 | ↑ | +6.6% | -8.0% |
| 2017.12 | 2017/11/09 | Q3予 | 380 | → | 0.0% | +31.0% | -680 | → | 0.0% | +55.4% | -720 | → | 0.0% | +52.9% | -1,670 | → | 0.0% | -15.6% |
| 2017.12 | 2017/08/10 | Q2予 | 380 | → | 0.0% | +31.0% | -680 | → | 0.0% | +55.4% | -720 | → | 0.0% | +52.9% | -1,670 | → | 0.0% | -15.6% |
| 2017.12 | 2017/07/13 | 修正予 | 380 | ↑ | +31.0% | +31.0% | -680 | ↑ | +55.4% | +55.4% | -720 | ↑ | +52.9% | +52.9% | -1,670 | ↓ | -15.6% | -15.6% |
| 2017.12 | 2017/05/15 | Q1予 | 290 | → | 0.0% | 0.0% | -1,525 | → | 0.0% | 0.0% | -1,530 | → | 0.0% | 0.0% | -1,445 | → | 0.0% | 0.0% |
| 2017.12 | 2017/02/23 | 当初予 | 290 | - | - | - | -1,525 | - | - | - | -1,530 | - | - | - | -1,445 | - | - | - |
| 2016.12 | 2017/02/14 | 実 | 168 | ↑ | +5.0% | +5.0% | -319 | ↑ | +19.4% | +19.4% | -304 | ↑ | +23.0% | +23.0% | -253 | ↑ | +17.3% | +17.3% |
| 2016.12 | 2016/08/10 | Q2予 | 160 | → | 0.0% | 0.0% | -396 | → | 0.0% | 0.0% | -395 | → | 0.0% | 0.0% | -306 | → | 0.0% | 0.0% |
| 2016.12 | 2016/02/12 | 当初予 | 160 | - | - | - | -396 | - | - | - | -395 | - | - | - | -306 | - | - | - |
| 2015.12 | 2016/02/12 | 実 | 61 | → | 0.0% | - | -290 | → | 0.0% | 0.0% | -295 | → | 0.0% | - | -296 | → | 0.0% | - |
| 2015.12 | 2016/02/10 | 修正予 | 61 | ↑ | - | - | -290 | - | - | - | -295 | ↓ | - | - | -296 | ↓ | - | - |
| 2015.12 | 2015/02/12 | 当初予 | 0 | - | - | - | - | - | - | - | 0 | - | - | - | 0 | - | - | - |
| 2014.12 | 2015/02/12 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2014.12 | 2014/12/02 | 修正予 | 80 | ↑ | +100.0% | +100.0% | -203 | ↑ | +16.5% | +16.5% | -200 | ↑ | +16.7% | +16.7% | -201 | ↑ | +16.6% | +16.6% |
| 2014.12 | 2014/11/13 | Q3予 | 40 | → | 0.0% | 0.0% | -243 | → | 0.0% | 0.0% | -240 | → | 0.0% | 0.0% | -241 | → | 0.0% | 0.0% |
| 2014.12 | 2014/08/12 | Q2予 | 40 | → | 0.0% | 0.0% | -243 | → | 0.0% | 0.0% | -240 | → | 0.0% | 0.0% | -241 | → | 0.0% | 0.0% |
| 2014.12 | 2014/05/14 | Q1予 | 40 | → | 0.0% | 0.0% | -243 | → | 0.0% | 0.0% | -240 | → | 0.0% | 0.0% | -241 | → | 0.0% | 0.0% |
| 2014.12 | 2014/02/13 | 当初予 | 40 | - | - | - | -243 | - | - | - | -240 | - | - | - | -241 | - | - | - |
| 2013.12 | 2014/02/13 | 実 | 80 | - | - | - | -208 | - | - | - | -221 | - | - | - | -222 | - | - | - |
